Skip to main content
. 2022 Nov 23;8(47):eabq6324. doi: 10.1126/sciadv.abq6324

Fig. 6. The human SNCA intronic enhancer clusters predominantly control its expression in brain.

Fig. 6.

(A) Schematic graph shows the position of gRNAs and the human SNCA gene structure in SNCA tg-L and SNCA EnKO rats. (B) Western blotting confirms the expression of hSNCA, rSNCA, and tSNCA in different brain regions of SNCA EnKO, SNCA tg-L, and Non-tg rats (n = 5 rats in each group). (C) Immunohistochemical staining of hSNCA and rSNCA in the brain of SNCA tg-L, SNCA EnKO, and Non-tg rats (n = 3 rats in each group). Scale bars, 2 mm. (D) Schematic representation of the primers used to amplify full-length human SNCA mRNA (384 bp in length) (left). RT-PCR determines the expression of full-length human SNCA mRNA in SNCA EnKO, SNCA tg-L, and Non-tg rats (right) (n = 3 rats in each group). (E) RT-qPCR determines the expression level of human SNCA mRNA in SNCA EnKO rats. SNCA tg-L rats were used as a control (n = 4 rats in each group). (F) H3K27ac and H3K4me3 ChIP-seq reveals the status of histone modifications of the human SNCA gene in SNCA tg-L and SNCA EnKO rats (blue arrow: H3K27ac modification downstream of the human SNCA gene in SNCA EnKO rat; red arrow: H3K27ac and H3K4me3 modification on the promoter of the human SNCA gene in SNCA EnKO rat; gray squares indicate the region that was deleted from the human SNCA gene in SNCA EnKO rat). (G) ChIP-qPCR quantitatively determines the histone modifications on the SNCA promoter in SNCA tg-L and SNCA EnKO rats (n = 4 rats in each group). ***P < 0.001; ****P < 0.0001. Comparison by unpaired two-tailed t test.